Xention Licenses Aureus Pharma's Ion Channel Knowledgebase | GenomeWeb

NEW YORK (GenomeWeb News) - Xention has licensed the AurSCOPE Ion Channel Knowledge database from Aureus Pharma to use in research, Aureus Pharma said today.
AurSCOPE Ion Channel contains biological information for all known ion channels and their ligands, Aureus said.
Xention is a drug discovery and development company that focuses on ion channels.
Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.